← Browse by Condition
Medical Condition
myeloproliferative neoplasms
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1
NCT07441694 Phase 1
Recruiting
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Enrollment
218 pts
Location
United States, Austr...
Sponsor
Incyte Corporation
NCT06034002 Phase 1
Recruiting
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Enrollment
230 pts
Location
United States
Sponsor
Incyte Corporation